Safety has to be assessed separately and carefully
These factors include how often the injections are administered and the metabolism rate of the person
Given retatrutide's superior Phase 2 weight loss data (24.2% vs 15-17% for semaglutide), priority review is possible
That gap is worth planning around: the beyond-use window of a reconstituted solution (covered in the storage section) can be shorter than the drug supply lasts, especially for the 10 mg vial, so re-order and reconstitution-volume decisions should be made against the shorter of the two limits the stability window or the drug supply not just the drug supply alone
Protein shakes become a practical tool during these phases, as liquid calories are often easier to consume than solid food when appetite is heavily suppressed
GIP (glucose-dependent insulinotropic polypeptide) is another gut hormone that, like GLP-1, helps regulate blood sugar and appetite, so activating both pathways may provide additional benefits